The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations ...
Federal health officials are reviewing the safety of two injectable drugs used to protect babies and toddlers from the RSV ...
FDA reexamine infant RSV therapies with Sanofi, AstraZeneca, and Merck amid safety concerns and data review under new FDA leadership.